N1VO34:BVMF
Novo Nordisk Bdr
R$ 23.92
0.00%
(0.00) Siku 1
13 Okt, 16:56:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya N1VO34...
Fungua
R$ 24.01
Juu
R$ 24.36
Chini
R$ 23.80
Mtaji wa soko
128.51B
Wastani wa kiasi cha mauzo
elfu 34.82
Kiasi cha mauzo ya hisa
elfu 8.45
Juu kwa wiki 52
R$ 42.43
Chini kwa wiki 52
R$ 22.90
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Fungua
R$ 24.01
Juu
R$ 24.36
Chini
R$ 23.80
Mtaji wa soko
128.51B
Wastani wa kiasi cha mauzo
elfu 34.82
Kiasi cha mauzo ya hisa
elfu 8.45
Juu kwa wiki 52
R$ 42.43
Chini kwa wiki 52
R$ 22.90
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Traders Union
·
saa 7 zilizopita
India emerges as a key hub in pharmaceutical companies’ anti-obesity business and research strategy
The Motley Fool
·
saa 14 zilizopita
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks
·
siku 1 iliyopita
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
Yahoo Finance
·
siku 1 iliyopita
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Wasifu
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Kuhusu Novo Nordisk Bdr
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 66.7
Lilianzishwa1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Tovutinovonordisk.com